Director
DIN: 10031391
Mitesh Navinchandra Gala is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at CRYPTIC HEALTHTECH LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10031391.Mitesh Navinchandra Gala has previously been associated with 1 company in roles such as Designated Partner.Mitesh Navinchandra Gala is currently involved in 2 different roles. Their most recent position is with RUDRAMAA INNOVATORS PRIVATE LIMITED as a Director. The first company Mitesh Navinchandra Gala was appointed to as a director was CRYPTIC HEALTHTECH LLP. Mitesh Navinchandra Gala is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mitesh Navinchandra Gala is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at CRYPTIC HEALTHTECH LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10031391.Mitesh Navinchandra Gala has previously been associated with 1 company in roles such as Designated Partner.Mitesh Navinchandra Gala is currently involved in 2 different roles. Their most recent position is with RUDRAMAA INNOVATORS PRIVATE LIMITED as a Director. The first company Mitesh Navinchandra Gala was appointed to as a director was CRYPTIC HEALTHTECH LLP. Mitesh Navinchandra Gala is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
9 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RUDRAMAA INNOVATORS PRIVATE LIMITED | Director | 18-Nov-2023 |